Eisai completes rolling BLA submission for subcutaneous maintenance dosing of Leqembi ® (lecanemab-irmb) in the US

Nov 1, 2024 - 08:00
Eisai completes rolling BLA submission for subcutaneous maintenance dosing of Leqembi ® (lecanemab-irmb) in the US

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow